"10.1371_journal.pone.0102577","plos one","2014-07-21T00:00:00Z","Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Mariena J A van der Plas; Matthias Mörgelin; Martin Malmsten; Artur Schmidtchen","Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden; Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden; Department of Pharmacy, Uppsala University, Uppsala, Sweden; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore","Conceived and designed the experiments: MK AS. Performed the experiments: MK PP GK MJAvdP M. Mörgelin M. Malmsten. Analyzed the data: MK. Contributed reagents/materials/analysis tools: M. Mörgelin M. Malmsten. Wrote the paper: MK AS.","Drs Malmsten and Schmidtchen are founders and own shares in XImmune AB, a company developing anti-inflammatory peptides for human therapy. All other authors have declared no competing interest exist. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Martina Kalle","MK",7,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
